Breaking News
Home / Business News (page 105)

Business News

Cardinal Health Studies Affirm Importance of Patient Reported Outcomes for Improved Quality and Reduced Costs of Care

Patient-reported outcomes (PRO) can improve quality and reduce costs of care for high-cost, complex diseases, according to new clinical studies published by Cardinal Health Specialty Solutions. The company is unveiling a series of studies at the International Society of Pharmacoeconomic and Outcomes Research (ISPOR) annual meeting in Philadelphia, May 16-20, …

Read More »

Evolution of Healthcare Driven by Science, Information and Technology

Advances in science, more readily available medical information and new technologies are driving evolution of global healthcare increasing patient engagement, improving diagnosis and treatment and enabling patients with life-threatening diseases to live longer and healthier lives, according to CSL Limited CEO and Managing Director Paul Perreault. “It’s all about diagnosing …

Read More »

Express Scripts Report Finds Patients Taking At Least $100,000 Worth of Prescription Drugs Nearly Tripled in 2014

In 2014, the number of US patients taking at least $100,000 worth of medication nearly tripled from the previous year, according to a new report released from Express Scripts. Express Scripts released its new report, Super Spending: U.S. Trends in High-Cost Medication Use, which examines prescription drug use among patients …

Read More »

FDA Panel Recommends Approval of Vertex’s Cystic Fibrosis Combo

A US Food and Drug Administration (FDA) advisory committee has recommended approval of Vertex Pharmaceuticals’ new combination therapy for treatment of cystic fibrosis (CF). The agency’s Pulmonary-Allergy Drugs Advisory Committee voted 12 to 1 in favor of approving the drug, which consists of Vertex’s already approved drug Kalydeco (ivacaftor) and …

Read More »

Lilly Enters Research Deal with BioNTech for New Cancer Immunotherapies

Pharma giant Eli Lilly and Company is teaming up with Germany-based BioNTech to discover novel cancer immunotherapies. The companies have entered into a research collaboration to discover new cancer drugs, which use the body’s own immune system to attack cancer cells and create possible new treatment options for patients with …

Read More »

First Nonprofit Organization Formed Dedicated to Biosimilars

A group of leading companies involved in the development of biopharmaceuticals and biosimilars have formed the first nonprofit organization dedicated to expanding patient access to biosimilars in the US. A coalition of eleven leading companies involved in developing and manufacturing biopharmaceuticals and biosimilar drugs announced the formation of the Biosimilars …

Read More »

Alexion Enhances its Rare Disease Business Acquiring Synageva for $8.4 Billion

Rare disease company Alexion Pharmaceuticals, Inc. agreed to acquire smaller rival Synageva BioPharma Corp for $8.4 billion in cash and stock, more than double its market value. The companies announced today that they have entered into a definitive agreement, under which Alexion will acquire Synageva for consideration for $115 in …

Read More »